Caffeine Compromises Proliferation of Human Hippocampal Progenitor Cells.
adult hippocampal neurogenesis
caffeine
diet
hippocampal progenitor integrity
hippocampal progenitor proliferation
Journal
Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250
Informations de publication
Date de publication:
2020
2020
Historique:
received:
08
06
2020
accepted:
31
07
2020
entrez:
5
10
2020
pubmed:
6
10
2020
medline:
6
10
2020
Statut:
epublish
Résumé
The age-associated reduction in the proliferation of neural stem cells (NSCs) has been associated with cognitive decline. Numerous factors have been shown to modulate this process, including dietary components. Frequent consumption of caffeine has been correlated with an increased risk of cognitive decline, but further evidence of a negative effect on hippocampal progenitor proliferation is limited to animal models. Here, we used a human hippocampal progenitor cell line to investigate the effects of caffeine on hippocampal progenitor integrity and proliferation specifically. The effects of five caffeine concentrations (0 mM = control, 0.1 mM ∼ 150 mg, 0.25 mM ∼ 400 mg, 0.5 mM ∼ 750 mg, and 1.0 mM ∼ 1500 mg) were measured following acute (1 day) and repeated (3 days) exposure. Immunocytochemistry was used to quantify hippocampal progenitor integrity (i.e., SOX2- and Nestin-positive cells), proliferation (i.e., Ki67-positive cells), cell count (i.e., DAPI-positive cells), and apoptosis (i.e., CC3-positive cells). We found that progenitor integrity was significantly reduced in supraphysiological caffeine conditions (i.e., 1.0 mM ∼ 1500 mg), but relative to the lowest caffeine condition (i.e., 0.1 mM ∼ 150 mg) only. Moreover, repeated exposure to supraphysiological caffeine concentrations (i.e., 1.0 mM ∼ 1500 mg) was found to affect proliferation, significantly reducing % Ki67-positive cells relative to control and lower caffeine dose conditions (i.e., 0.1 mM ∼ 150 mg and 0.25 mM ∼ 400 mg). Caffeine treatment did not influence apoptosis and there were no significant differences in any measure between lower doses of caffeine (i.e., 0.1 mM, 0.25 mM, 0.5 mM) - representative of daily human caffeine intake - and control conditions. Our study demonstrates that dietary components such as caffeine can influence NSC integrity and proliferation and may be indicative of a mechanism by which diet affects cognitive outcomes.
Identifiants
pubmed: 33015033
doi: 10.3389/fcell.2020.00806
pmc: PMC7505931
doi:
Types de publication
Journal Article
Langues
eng
Pagination
806Subventions
Organisme : Medical Research Council
ID : MR/N030087/1
Pays : United Kingdom
Informations de copyright
Copyright © 2020 Houghton, Du Preez, Lefèvre-Arbogast, de Lucia, Low, Urpi-Sarda, Ruigrok, Altendorfer, González-Domínguez, Andres-Lacueva, Aigner, Lucassen, Korosi, Samieri, Manach and Thuret.
Références
Eur J Neurol. 2011 May;18(5):756-65
pubmed: 21281405
Exp Neurol. 2011 Jan;227(1):218-23
pubmed: 21087606
Stem Cells Transl Med. 2019 Nov;8(11):1202-1211
pubmed: 31313515
J Neurophysiol. 2005 Dec;94(6):4224-33
pubmed: 16014798
Am J Alzheimers Dis Other Demen. 2008 Oct-Nov;23(5):417-22
pubmed: 19230121
Trends Endocrinol Metab. 2016 Nov;27(11):756-769
pubmed: 27387597
Development. 2004 Aug;131(15):3805-19
pubmed: 15240551
Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1492-6
pubmed: 22790876
PLoS One. 2017 Nov 20;12(11):e0184923
pubmed: 29155843
Nat Rev Neurosci. 2006 Mar;7(3):179-93
pubmed: 16495940
Mol Psychiatry. 2011 Jul;16(7):738-50
pubmed: 21483429
Int J Food Sci Nutr. 2013 Jun;64(4):429-36
pubmed: 23301724
Autophagy. 2011 Feb;7(2):176-87
pubmed: 21081844
Neurobiol Aging. 2004 Mar;25(3):361-75
pubmed: 15123342
Nutrition. 2010 Oct;26(10):932-8
pubmed: 20888549
Neuroepidemiology. 2016;47(3-4):192-200
pubmed: 28135712
Neurology. 2007 Aug 7;69(6):536-45
pubmed: 17679672
Pharmacogenetics. 1992 Jun;2(3):116-27
pubmed: 1306111
J Neurosci. 2013 Mar 6;33(10):4216-33
pubmed: 23467340
Neurosci Lett. 2007 Mar 26;415(2):154-8
pubmed: 17240063
Eur J Neurosci. 2011 Sep;34(6):978-87
pubmed: 21929629
Cold Spring Harb Perspect Biol. 2016 Jun 01;8(6):
pubmed: 26438595
Behav Brain Res. 2020 Mar 2;381:112458
pubmed: 31899214
Br J Clin Pharmacol. 1999 Apr;47(4):445-9
pubmed: 10233211
Toxicol In Vitro. 2013 Sep;27(6):1830-7
pubmed: 23727198
Stem Cells Dev. 2011 Jul;20(7):1153-61
pubmed: 21028992
Cell. 2016 Nov 3;167(4):897-914
pubmed: 27814520
J Cell Mol Med. 2013 Nov;17(11):1434-43
pubmed: 24034597
FEBS Lett. 2019 Dec;593(23):3338-3352
pubmed: 31529465
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Oct 1;32(7):1698-703
pubmed: 18675877
Handb Exp Pharmacol. 2011;(200):33-91
pubmed: 20859793
Ageing Res Rev. 2018 Mar;42:40-55
pubmed: 29248758
Stem Cells. 2008 Aug;26(8):1931-8
pubmed: 18388306
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3168-71
pubmed: 9501234
Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1255-60
pubmed: 19171901
Curr Opin Cell Biol. 2011 Dec;23(6):724-9
pubmed: 21930368
Nat Clin Pract Neurol. 2009 Mar;5(3):140-52
pubmed: 19262590
Sports Med. 2001;31(11):785-807
pubmed: 11583104
Mol Psychiatry. 2013 Apr;18(4):404-16
pubmed: 23439487
Stem Cells Int. 2013;2013:973508
pubmed: 24260036
Biochem Biophys Res Commun. 2007 May 18;356(4):976-80
pubmed: 17400186
Dev Cell. 2014 Aug 11;30(3):309-21
pubmed: 25065772
Commun Biol. 2020 Apr 2;3(1):157
pubmed: 32242137
J Neurosci. 2010 May 12;30(19):6635-45
pubmed: 20463226
J Neurobiol. 1999 Jun 15;39(4):569-78
pubmed: 10380078
Neuropharmacology. 2009 May-Jun;56(6-7):994-1000
pubmed: 19217915
Cell. 2010 Dec 23;143(7):1161-73
pubmed: 21183078
Mol Carcinog. 2005 Sep;44(1):67-76
pubmed: 16044420
Aging Cell. 2006 Dec;5(6):545-58
pubmed: 17129216
Cell. 2013 Jun 6;153(6):1219-1227
pubmed: 23746839
Nat Neurosci. 2009 Oct;12(10):1248-56
pubmed: 19734891
Mol Nutr Food Res. 2019 Sep;63(18):e1900177
pubmed: 31218777
Development. 2008 Feb;135(3):541-57
pubmed: 18171687
Pharmacol Rev. 2018 Apr;70(2):384-411
pubmed: 29514871
Neuron. 2019 Jan 2;101(1):32-44.e6
pubmed: 30497772
Neuroscience. 2020 Jan 10;:
pubmed: 31930958
Eur Neuropsychopharmacol. 2010 Jan;20(1):1-17
pubmed: 19748235
Genes Nutr. 2009 Dec;4(4):271-82
pubmed: 19685256
Eur J Neurol. 2006 Dec;13(12):1385-8
pubmed: 17116226
Neurobiol Aging. 2005 Dec;26 Suppl 1:46-9
pubmed: 16219391
Genet Mol Res. 2016 Apr 04;15(2):
pubmed: 27173183
Food Funct. 2014 Aug;5(8):1718-26
pubmed: 25014672
J Alzheimers Dis. 2011;27(3):553-66
pubmed: 21841254
Cell Stem Cell. 2018 Jul 05;23(1):25-30
pubmed: 29681514
Clin Toxicol (Phila). 2016;54(4):308-12
pubmed: 27100333
Nature. 2011 Aug 31;477(7362):90-4
pubmed: 21886162
Science. 2009 Jul 10;325(5937):210-3
pubmed: 19590004
Science. 2003 Aug 8;301(5634):805-9
pubmed: 12907793
Nat Med. 2019 Jun;25(6):988-1000
pubmed: 31086348
J Neurosci. 2005 Sep 21;25(38):8680-5
pubmed: 16177036
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479
Neuroscience. 2005;130(4):843-52
pubmed: 15652983
Prog Neurobiol. 2019 May;176:120-133
pubmed: 29772255
Nutrients. 2020 Feb 22;12(2):
pubmed: 32098348
Psychopharmacology (Berl). 2016 May;233(10):1963-79
pubmed: 26786412
Nature. 2011 Apr 28;472(7344):466-70
pubmed: 21460835
Ann Neurol. 2002 Mar;51(3):290-5
pubmed: 11891823
Wiley Interdiscip Rev Cogn Sci. 2014 Sep;5(5):573-587
pubmed: 26308746
Stem Cells. 2010 Dec;28(12):2162-71
pubmed: 20963821
FASEB J. 2019 Apr;33(4):5729-5740
pubmed: 30673509
Front Neuroanat. 2018 Jun 05;12:44
pubmed: 29922131